Abstract −The present study was undertaken to determine whether hypoxia influences on the agonist-induced vascular smooth muscle contraction and, if so, to investigate the related mechanism. The measurement of isometric contractions using a computerized data acquisition system was combined with molecular experiments. Hypoxia significantly inhibited fluoride-induced contraction regardless of endothelial function, but there was no relaxation on thromboxane A 2 mimetic U-46619-induced contraction suggesting that other pathway such as Ca 2+ entry or thin filament regulation was not affected. In addition, hypoxia significantly decreased fluorideinduced increase of phospho-myosin-targeting subunit of myosin light chain phosphatase (pMYPT1). Interestingly, hypoxia didn't inhibit significantly phenylephrine-induced contraction suggesting that myosin light chain kinase (MLCK) activity or thin filament regulation is less important on the hypoxia-induced vasorelaxation in the denuded muscle than Rho-kinase activity. In conclusion, this study provides the evidence and possible related mechanism concerning the vasodilation effect of hypoxia on the agonist-specific contraction in rat aortic rings regardless of endothelial function.
INTRODUCTION
Systemic vessels such as arteries or arterioles lie within the tissue they are supplying and can be acted on by local factors within the tissue relax in response to acute hypoxia (Shimizu, et al., 2000) , which leads to a better tissue perfusion (Young and Vatner, 1986) . It was reported that there was no decrease in intracellular Ca 2+ in hypoxia-induced vascular relaxation (Ishida and Honda, 1992; Aalkjaer and Lombard, 1995; Shimizu, et al., 2000) . Since Ca 2+ remains elevated and force decreases, it can be called as Ca 2+ desensitization (Shimizu, et al., 2000) .
It is generally accepted that the initiation of smooth muscle contractility is predominantly controlled by a Ca 2+ -dependent increase in myosin light chain 20 kDa (MLC 20 ) phosphorylation (Somlyo and Somlyo, 1994) . However, other pathways have now been described that may regulate the contractility of smooth muscle by regulating the phosphorylation of MLC 20 independently of a rise in intracellular Ca 2+ (Somlyo and Somlyo, 1998; Uehata, et al., 1997; Sakurada, et al., 2003) . The phosphorylation of MLC 20 promotes the interaction of actin and myosin II, and the contraction of smooth muscle. The degree of MLC 20 phosphorylation or contraction does not always parallel the Ca 2+ concentration. The extent of MLC 20 phosphorylation or force of contraction induced by agonist stimulation is usually higher than that caused by an increase in the Ca 2+ concentration, a finding explained by so-called Ca 2+ sensitization (Somlyo and Somlyo, 1994) . Thus, an additional mechanism of regulation that modulates the levels of MLC 20 phosphorylation and degree of contraction has been proposed. Subsequent studies have revealed that inhibition of MLC phosphatase by Rhokinase (Kitazawa, et al., 1991) or thin filament regulation including activation of protein kinase C (PKC), mitogenactivated protein kinase kinases (MEK) and extracellular signal regulated kinase (ERK) 1/2, and phosphorylation of the actin binding protein caldesmon (Wier and Morgan, 2003) may be the major pathway in Ca 2+ sensitization. In various smooth muscles, phenylephrine has been shown to induce contraction, which may be due to enhancement of Ca 2+ sensitivity. Phenylephrine has been known to induce contraction in blood vessel preparations leading to either thick or thin filament regulation. Thick or myosin filament regulation encompasses both Ca 2+ activation and Ca 2+ sensitization as it involves both activation of MLCK by Ca 2+ -calmodulin and regulation of MLCP activity. On the other hand, thin or actin filament regulation includes the possible disinhibition of actin-myosin interactions by phosphorylation of caldesmon, possibly by PKC, MEK or ERK that are translocated during their activation (Gerthoffer, et al., 1996) . It is possible that fluoride-or thromboxane A 2 mimetic-induced contractions involve the participation of the RhoA/Rho-kinase pathway (Tsai and Jiang, 2006; Jeon, et al., 2006) . Therefore, the aim of the present study was to elucidate the possible role of thick filament regulation such as Rhokinase inhibition or thin filament regulation on Ca 2+ desensitization in hypoxia-induced relaxation of isolated rat aortae using RhoA/Rho-kinase activators such as fluoride or thromboxane A 2 mimetic.
Materials and methods

Tissue preparation
Male Sprague-Dawley rats, weighing 320-350 g, were anesthetized by sodium pentobarbital (50 mg/kg i.p.) followed by cervical dislocation, in agreement with procedures approved by the Institutional Animal Care and Use Committee. The thoracic aorta was quickly removed and immersed in oxygenated (95 % O 2 /5% CO 2 ) physiological saline solution composed of (mM): 115.0 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2 MgCl 2 , 25.0 NaHCO 3 , 1.2 KH 2 PO 4 , and 10.0 dextrose (pH 7.4). The aorta was cleaned of all adherent connective tissue, and the endothelium was removed by gentle abrasion with a cell scraper.
Contraction measurements
Sometimes care was taken to avoid rubbing the endothelial surface of the vessels that had intact endothelium. Two stainless-steel triangles were inserted through each vessel ring. Each aortic ring was suspended in a waterjacketed organ bath (20 ml) maintained at 37 o C and aerated with a mixture of 95% O 2 and 5% CO 2 . One triangle was anchored to a stationary support, and the other was connected to an isometric force transducer (Grass FT03C, Quincy, Mass., USA). The rings were stretched passively by imposing the optimal resting tension, 2.0 g, which was maintained throughout the experiment. Each ring was equilibrated in the organ bath solution for 60 min before the experiment involving the contractile response to 50 mM KCl addition. Isometric contractions were recorded using a computerized data acquisition system (PowerLab/8SP, ADInstruments, Castle Hill, NSW, Australia).
After completion of the control KCl dose-response curve, vessel rings were pre-incubated with hypoxia or no aeration. Aeration or no aeration was applied 1 min before the addition of fluoride, thromboxane A 2 mimetic or phenylephrine. The absence of the endothelium was verified by the lack of relaxation after the addition of acetylcholine (1 µM) to precontracted ring segments.
Western blot analysis
Muscle strips were quick frozen by immersion in a dry ice/acetone slurry containing 10% trichloroacetic acid (TCA) and 10 mM dithiothreitol (DTT). Muscles were stored at -80 o C until used. Tissues were brought to room temperature in a dry ice/acetone/ TCA/DTT mixture. Then samples were homogenized in a buffer containing 20 mM mops, 4% SDS, 10% glycerol, 10 mM DTT, 20 mM β-glycerophosphate, 5.5 µM leupeptin, 5.5 µM pepstatin, 20 KIU aprotinin, 2 mM Na 3 VO 4 , 1 mM NaF, 100 µM ZnCl 2 , 20 µM 4-(2-aminoethyl) benzenesulphonyl fluoride (AEBSF) and 5 mM EGTA. Protein-matched samples (modified Lowry protein assay, DC Protein Assay Kit, Bio-Rad) were electrophoresed on SDS-PAGE (Protogel, National Diagnostics), transferred to PVDF membranes and subjected to immunostaining and densitometry, as above, using the appropriate antibody. The success of protein matching was confirmed by Naphthol Blue Black staining of the membrane and densitometry of the actin band. Any mismatch of lane loading was corrected by normalization to actin staining. Each set of samples from an individual experiment was run on the same gel and densitometry was performed on the same film.
Chemicals and antibodies
The drugs and chemicals were reagent grade unless otherwise indicated and obtained from the following source. Sodium fluoride, U-46619, KCl, acetylcholine, Y-27632 and nicardipine were purchased from Sigma Co. (St. Louis, MO, USA). DTT, TCA and acetone were obtained from Fisher Scientific (Hampton, NH, USA) and enhanced chemiluminescence (ECL) from Pierce (Rockford, IL, USA). The antibody against phospho-myosin-targeting subunit of myosin light chain phosphatase (phospho-MYPT1) at Thr855 (1:5,000) or MYPT1 was purchased from Upstate Biotechnology (Lake Placid, NY, USA) or BD Biosciences (San Jose, CA, USA) to check the level of RhoA/Rho-kinase activity (Wilson et al., 2005; Wooldridge et al., 2004) . Anti-mouse IgM (goat) and anti-rabbit IgG (goat), conjugated with horseradish peroxidase, were used as secondary antibodies (1:2,000, 1:2,000, respectively, Upstate, Lake Placid, NY). Acetylcholine was dissolved in deionized water.
Statistical analysis
The data were expressed as mean ± standard error of the mean (SEM). Student's unpaired t test was used to determine the statistical significance of the means between two groups using SPSS 12.0 (SPSS Inc., Chicago, Illinois, U.S.A.). P values < 0.05 were regarded as statistically significant.
RESULTS
Effect of hypoxia on phenylephrine-induced contraction of denuded aortae
The absence of the endothelium was verified by the lack of relaxation after the addition of acetylcholine (1 µM) to precontracted ring segments. Hypoxia didn't inhibit significantly phenylephrine-induced contraction regardless of endothelial function (Fig. 1) suggesting that MLCK or thin filament regulation might be of little importance.
Effect of hypoxia on fluoride-induced contraction of denuded aortae
Hypoxia completely inhibited Rho-kinase activator fluoride-induced contraction regardless of endothelial function (Fig. 2, Fig. 3 ) suggesting that Rho-kinase might be inhibited in the relaxation.
Effect of hypoxia on the level of phospho-MYPT1 at Thr-855
To confirm the role of hypoxia in thick filament regulation of smooth muscle contractility, we measured the levels of myosin-targeting subunit of myosin light chain phosphatase (MYPT1) and phospho-MYPT1 in the muscles quick frozen after 30 min exposure to 8 mM fluoride. 1 µM Y-27632 was coadministrated with hypoxia. Interestingly, there was a significant decrease in the 8 mM fluoride-induced MYPT1 phosphorylation at Thr855, the newly-highlighted site, instead of Thr697 (Wilson, et al., 2005; Tsai and Jiang, 2006) in quick frozen hypoxiatreated rat aorta in the absence of endothelium compared to the vehicle treated rat aorta (Fig. 4) . Thus thick or myosin filament regulation including myosin phosphatase activation through RhoA/Rho-kinase inactivation might be partly involved in decreased contractility in hypoxia treated rat aorta.
Effect of hypoxia on thromboxane A 2 -induced contraction of denuded aortae.
Pretreated no-aeration or hypoxia didn't significantly inhibit Rho-kinase activator thromboxane A 2 mimetic U-46619-induced contraction regardless of endothelial function (Fig. 5) suggesting that Rho-kinase activity might be inhibited and other pathways than RhoA/Rho-kinase pathway might be involved in thromboxane A 2 mimetic U-46619-induced Ca 2+ sensitization such as Ca 2+ entry or the phosphylation of extracellular signal-regulated kinase (ERK), protein kinase C-potentiated inhibitory protein for protein phosphatase type 1 (CPI-17) or integrin-linked kinase (ILK) (47,48).
DISCUSSION
When the blood supply to a region is completely occluded leading to the hypoxia, arterioles in the region dilate because of myogenic relaxation, which occurs in response to the diminished stretch accompanying no blood flow, and changes in local chemical composition. Many of the same chemical changes occur in blooddeprived tissues that occur during metabolically induced active hyperemia. When a tissue's blood supply is blocked, O 2 levels decrease in the deprived tissue because the tissue continues to consume O 2 , but no fresh supplies are being delivered. After the occlusion is removed, blood flow to the previously deprived tissue is transiently much higher than normal because the arterioles are widely dilated. Such a response is beneficial for rapidly restoring the local chemical composition including O 2 or CO 2 to normal. It was reported that the effect of hypoxia included vasodilation (Shimizu, et al., 2000) . This study has investigated whether the inhibition of RhoA/ Rho-kinase activity contributes to the hypoxia-induced vascular relaxation in rat aortae contracted with a RhoA/ Rho-kinase activator such as fluoride or thromboxane A 2 .
Two mechanisms are postulated for the development of contraction and myosin light chain 20 kDa (MLC 20 ) phosphorylation in smooth muscle. The first mechanism is that elevation in [Ca 2+ ] i activates a Ca 2+ -calmodulindependent myosin light chain kinase (MLCK), which in turn catalyzes phosphorylation of MLC 20 , leading to cross bridge cycling and contraction (Murphy, 1982) . A decrease in the concentration of intracellular Ca 2+ inactivates MLCK and allows MLC phosphatase to dephosphorylate MLC 20 , resulting in muscle relaxation. A second mechanism of vascular smooth muscle contraction involves Rho-kinase (Amano, et al., 1996) , whose activity is dependent on activation of the small GTP-binding protein RhoA. The RhoA/Rho-kinase pathway plays a key role in the Ca 2+ sensitization of smooth muscle contraction, which is mainly induced by MLC phosphatase inhibition (Noda, et al., 1995; Somlyo and Somlyo, 2000) .
The mechanism by which fluoride activates G-proteins has been clearly established (Kanaho, et al., 1985; Blackmore and Exton, 1986; Cockcroft and Taylor, 1987) . It has been reported that the effect of fluoride on heterotrimeric G protein is the result of formation of AlF 4 -from fluoride and trace amounts of aluminum, which can come from contamination of glassware (Zeng, et al., 1989; Chabre, 1990) , and the structural similarity of AlF 4 -to PO 4 3-enabling to interact with GDP situated on the α-subunit of the G proteins where it can mimic GTP (Bigay, et al., 1985) . Fluoride is also a classical Ser/Thr phosphatase inhibitor (Shenolikar and Nairn, 1991) and is routinely included in extraction buffers to prevent dephosphorylation of proteins on Ser and Thr residues by endogenous phosphatases. On the other hand, previous studies examining the mechanisms of thromboxane A 2 mimetic U46619-induced arterial contraction have reported variable findings with regard to the contraction related to Rho-kinase activation (Nobe and Paul, 2001; Tasaki, et al., 2003; Wilson, et al., 2005) . Therefore, it was consistent with the possibility that the hypoxia could decrease fluoride-or thromboxane A 2 mimetic-induced contraction inhibiting Rho-kinase activity.
The mechanisms by which Rho-kinase activation causes vascular contraction is an area of intense study, and several possibilities exist. For example, Rho-kinase phosphorylates myosin light chain phosphatase, resulting in decreased phosphatase activity and a buildup of phosphorylated myosin light chains (Somlyo and Somlyo, 2000; Pfitzer 2001 ). Rho-kinase has also been demonstrated to directly phosphorylate myosin light chains independently of myosin light chain kinase and phosphatase activity (Amano, et al., 1996) . Recently, a role for Rho-kinase in vascular contraction evoked by sodium fluoride or thromboxane A 2 was established (Tsai and Jiang, 2006; Jeon, et al., 2006; Wilson, et al., 2005) . Because fluoride-induced contraction was completely blocked by the hypoxia, it seems likely that under our experimental conditions, Rho-kinase inactivation may be the main pathway in the hypoxia-induced relaxation (Fig.  2, Fig. 3) .
The main finding of the present study is that hypoxia completely inhibited fluoride-induced contraction regardless of endothelial function (Fig. 2, Fig. 3) , and hypoxia didn't decrease thromboxane A 2 -induced vasoconstriction regardless of endothelial function compared to fluoride-induced contraction (Fig. 5) suggesting some difference between the mechanisms of RhoA/Rho-kinase activators such as fluoride and thromboxane A 2 . Therefore, we postulated that other pathways than RhoA/Rho-kinase pathway might be involved in thromboxane A 2 mimetic U-46619-induced Ca 2+ sensitization suggesting that hypoxia might not inhibit Ca 2+ entry (Davis, et al., 2001; Low, 1996) or the phosphylation of extracellular signal-regulated kinase (ERK), protein kinase C-potentiated inhibitory protein for protein phosphatase type 1 (CPI-17) or integrin-linked kinase (ILK) (Deng, et al., 2001; Muranyi, et al., 2002) . Furthermore, hypoxia decreased fluorideinduced phosphorylation of MYPT1 at Thr855, the newlyhighlighted site, instead of Thr697 (Fig. 4) suggesting inhibition of Rho-kinase activity and indicating that the relaxation mechanism of hypoxia is similar to that of Y-27632. Therefore, suffice it to say that Rho-kinase inhibition is the major mechanism in hypoxia-induced vasorelaxation at least in the denuded and fluoride-contracted muscle, and the above-mentioned other pathways than RhoA/Rho-kinase pathway might be involved in thromboxane A 2 mimetic-induced Ca 2+ sensitization. In summary, our results indicate that the hypoxia completely attenuated not thromboxane A 2 -but fluorideinduced contraction in rat aortic rings regardless of endothelial function suggesting additional Ca 2+ entry or the phosphorylation of ERK, CPI-17 or ILK besides RhoA/ Rho-kinase pathway existed in thromboxane A 2 -induced contraction. The possible relaxing mechanism of the hypoxia in fluoride-induced contraction of the denuded muscle includes inhibition of Rho-kinase activity suggesting that other pathway is less important on the hypoxiainduced vasorelaxation in agonist-dependent contraction of the denuded muscle. Subsequent interactions between myosin phosphatase and weakened Rho-kinase may lead to attenuated Ca 2+ sensitivity of the myofilament and vascular relaxation.
